Individuals meeting the following criteria between January 1, 2015 and December 31, 2021:  Diabetes mellitus (DM) type II HbA1c of 7-11% within the past year Monotherapy with metformin for at least 3 months No prior non-metformin outpatient diabetes therapy Aged ≥30y  At "moderate" risk of ASCVD  Men aged ≥35y and women aged ≥45y with no history* of stroke, myocardial infarction, revascularization, or heart failure hospitalization Men aged 30-34 and women aged 30-44 with history* of hypertension, hyperlipidemia, retinopathy, kidney disease or neuropathy estimated glomerular filtration rate (eGFR) ≥ 45 ml/min/1.73m2 within the past 3 years Not pregnant at time 0 No history* of institutionalization with a diagnosis of dementia, metastatic cancer, end stage lung disease, end stage liver disease, pancreatitis, medullary thyroid cancer or severe UTIs Engagement with the healthcare system: enrollment for at least 12 months and attendance of at least one outpatient encounter in the prior 12 months  (*) History will be derived from at least 12 months of EHR and claims prior to time zero and will use all available EHR and claims data between January 1, 2014 and time zero